Tianjin
Tianjin
Tianjin, Tianjing, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SYH2095 for Advanced Malignant Tumors: Phase I Study | Advanced Malignant Tumors | Not yet recruiting | Not stated | 2026-07-09 | NCT07692776 | |
| CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I) | Neovascular Age-related Macular Degeneration(nAMD) | Recruiting | Early phase 1 | 2025-03-17 | NCT06031727 |